Arecor Therapeutics PLC (GB:AREC) has released an update.
Arecor Therapeutics PLC, a biopharmaceutical company specializing in enhancing therapies for better patient care, is set to release its interim results for the first half of 2024 on September 26, with a briefing by CEO Sarah Howell in London. The company is known for its Arestat™ technology platform, which is backed by a robust patent portfolio and aims to develop an internal portfolio of proprietary products, as well as collaborations with leading pharmaceutical and biotech firms.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.
